Obstetrics & Gynecology · Salina, KS
NPI
1841256930
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
737 E Crawford St
Salina, KS, 67401
Phone (785) 827-7261
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,639 services
Medicare patients, 2024
201
Average age 72
Drug cost, 2024
$29K
857 prescriptions
Company payments, 2025
$354
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Prendergast was code 99214 (office e&m - established), 130 times for 128 patients. In total David C Prendergast billed 1,639 services in 76 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 130 | 128 | $71.72 | $9,324 |
| 99213 Office E&M - Established | Office | 119 | 49 | $58.33 | $6,941 |
| 77063 Mammography | Office | 84 | 84 | $47.71 | $4,008 |
| 77067 Mammography | Office | 84 | 84 | $115.54 | $9,705 |
| 99459 Office/Outpatient Services | Office | 45 | 40 | $9.77 | $440 |
| 36415 Venipuncture Blood Collection | Office | 44 | 30 | $8.65 | $381 |
| 80053 Clinical Chemistry | Office | 34 | 24 | $10.35 | $352 |
| 85025 Blood Count | Office | 26 | 22 | $7.61 | $198 |
| 80061 Clinical Chemistry | Office | 20 | 17 | $13.12 | $262 |
| 81001 Clinical Chemistry | Office | 20 | 12 | $3.11 | $62.2 |
| 87210 General Laboratory | Office | 19 | 13 | $5.70 | $108 |
| 87220 General Laboratory | Office | 19 | 13 | $4.18 | $79.42 |
| 84443 Clinical Chemistry | Office | 14 | 12 | $16.46 | $230 |
| 99203 Office E&M - New | Office | 11 | 11 | $74.45 | $819 |
By year: 2022 $52K for 1,359 services; 2023 $54K for 1,356 services; 2024 $59K for 1,639 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 44 | 30 | $8.65 | $381 |
| 80053 Clinical Chemistry | 34 | 24 | $10.35 | $352 |
| 85025 Blood Count | 26 | 22 | $7.61 | $198 |
| 80061 Clinical Chemistry | 20 | 17 | $13.12 | $262 |
| 81001 Clinical Chemistry | 20 | 12 | $3.11 | $62.2 |
| 87220 General Laboratory | 19 | 13 | $4.18 | $79.42 |
| 87210 General Laboratory | 19 | 13 | $5.70 | $108 |
| 84443 Clinical Chemistry | 14 | 12 | $16.46 | $230 |
Medicare prescription drug claims, 2024
In 2024, the drug David C Prendergast prescribed most often to Medicare patients was Estradiol, with 126 prescriptions and refills. In total David C Prendergast wrote 857 Medicare prescriptions that cost $29K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 126 | 256 | 36 | $4,062 |
| Escitalopram Oxalate Generic | 44 | 62 | Under 11 | $289 |
| Simvastatin Generic | 41 | 77 | Under 11 | $102 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 40 | 70 | Under 11 | $505 |
| Atorvastatin Calcium Generic | 36 | 106 | Under 11 | $149 |
| Premarin Estrogens, Conjugated | 35 | 65 | Under 11 | $13K |
| Amlodipine Besylate Generic | 35 | 53 | Under 11 | $39.85 |
| Betamethasone Valerate Generic | 27 | 32 | 11 | $674 |
| Valacyclovir Valacyclovir Hcl | 20 | 36 | Under 11 | $570 |
| Medroxyprogesterone Acetate Generic | 19 | 33 | Under 11 | $78.35 |
| Hydrochlorothiazide Generic | 18 | 52 | Under 11 | $61.44 |
| Benazepril Hcl Generic | 17 | 25 | Under 11 | $164 |
| Sprintec Norgestimate-Ethinyl Estradiol | 14 | 14 | Under 11 | $397 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 13 | 15 | Under 11 | $63.89 |
| Sertraline Hcl Generic | 13 | 13 | Under 11 | $0 |
Brand drugs: 71 claims; generic drugs: 786 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Prendergast $354 ($354 in general payments such as food, travel and fees) from 10 companies. The largest payer was Astellas Pharma US Inc with $61.38.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 4 | $61.38 |
| Dexcom, Inc. DXCM | 3 | $58.66 |
| CONMED Corporation CNMD | 1 | $49.92 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $46.79 |
| CooperSurgical, Inc. COO | 2 | $35.07 |
| Pfizer Inc. PFE | 1 | $24.21 |
| Pharmacosmos Therapeutics Inc. | 1 | $22.8 |
| Novo Nordisk Inc NVO | 1 | $20.18 |
| Abbvie Inc. ABBV | 1 | $19.44 |
| Exeltis, USA Inc. | 1 | $15.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.